← All trials
NCT02174757
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2014
- Primary completion
- Nov 1, 2014
- Completion date
- Nov 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 30
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- CD Pharma India Pvt. Ltd.Lead sponsor
- Sree Mookambika Institute of Dental SciencesOverall official - principal investigator
- Sree Mookambika Institute of Dental SciencesStudy director
- Sree Mookambika Institute of Dental SciencesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.